Table 2.
Percentage description of type 2 diabetes (T2D), Impaired fasting glucose (IFG)/T2D, hypertension, waist-hip-ratio, waist circumference and body mass index by age group and by gender among 1623 study participants in Yaoundé, Cameroon, 2007
| Men (n = 666) | Women (n = 957) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25-34 | 35-44 | 45-54 | 55-64 | >65 | p-value 7 | 25-34 | 35-44 | 45-54 | 55-64 | >65 | p-value 7 | |||
| N | 666 | 317 | 100 | 116 | 100 | 33 | 957 | 451 | 178 | 221 | 70 | 37 | ||
| Variable | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | N (%) | ||
| T2D1 | 28 (4.2) | 3 (10.7) | 1 (3.6) | 8 (28.6) | 14 (50.0) | 2 (7.1) | <0.001 | 26 (2.7) | 4 (15.4) | 4 (15.4) | 10 (38.5) | 6 (23.1) | 2 (7.7) | <0.001 |
| IFG/T2D2 | 45 (6.8) | 5 (11.1) | 8 (17.8) | 9 (20.0) | 21 (46.7) | 2 (4.4) | <0.001 | 48 (5.0) | 9 (18.8) | 8 (16.7) | 20 (41.7) | 8 (16.6) | 3 (6.2) | <0.001 |
| Hypertension3 | 203 (30.5) | 37 (18.2) | 21 (10.3) | 58 (28.6) | 59 (29.1) | 28 (13.8) | <0.001 | 229 (23.9) | 35 (15.3) | 24 (10.5) | 101 (44.1) | 43 (18.8) | 26 (11.4) | <0.001 |
| Weight status4 | ||||||||||||||
| Normal weight | 314 (47.2) | 195 (62.1) | 38 (12.1) | 33 (10.5) | 32 (10.2) | 16 (5.1) | 279 (29.2) | 185 (66.3) | 38 (13.6) | 28 (10.0) | 15 (5.4) | 13 (4.7) | ||
| Overweight | 243 (36.5) | 95 (39.1) | 41 (16.9) | 54 (22.2) | 44 (18.1) | 9 (3.7) | 319 (33.3) | 157 (49.2) | 60 (18.8) | 71 (22.3) | 22 (6.9) | 9 (2.8) | ||
| Obese | 109 (16.4) | 27 (24.8) | 21 (19.3) | 29 (26.6) | 24 (22.0) | 8 (7.3) | <0.001 | 359 (37.5) | 109 (30.4) | 80 (22.3) | 122 (33.9) | 33 (9.2) | 15 (4.2) | <0.001 |
| Waist-hip-ratio5 | ||||||||||||||
| Normal | 414 (62.2) | 280 (67.6) | 58 (14.0) | 40 (9.7) | 29 (7.0) | 7 (1.7) | 615 (64.3) | 340 (55.3) | 118 (19.2) | 116 (18.9) | 29 (4.7) | 12 (1.9) | ||
| Elevated | 252 (37.8) | 37 (14.7) | 42 (16.7) | 76 (30.2) | 71 (28.2) | 26 (10.3) | <0.001 | 342 (35.7) | 111 (32.5) | 60 (17.5) | 105 (30.7) | 41 (12.0) | 25 (7.3) | <0.001 |
| Waist circumference6 | ||||||||||||||
| Normal | 485 (72.8) | 287 (59.2) | 64 (13.2) | 65 (13.4) | 52 (10.7) | 17 (3.5) | 258 (27.0) | 185 (71.7) | 40 (15.5) | 21 (8.1) | 8 (3.1) | 4 (1.6) | ||
| Increased risk | 98 (14.7) | 23 (23.5) | 17 (17.4) | 23 (23.5) | 28 (28.6) | 7 (7.1) | 215 (22.5) | 113 (52.6) | 33 (15.4) | 43 (20.0) | 15 (7.0) | 11 (5.1) | ||
| Elevated | 83 (12.5) | 7 (8.4) | 19 (22.9) | 28 (33.7) | 20 (24.1) | 9 (10.8) | <0.001 | 484 (50.6) | 153 (31.6) | 105 (21.7) | 157 (32.4) | 47 (9.7) | 22 (4.6) | <0.001 |
1FCG > =7.0 mmol/l and /or on diabetes medication.
2FCG > =6.1 mmol/l and /or on diabetes medication.
3SBP ≥ 140 and /or DBP ≥ 90 mmHg and / or on hypertensive medication.
4Normal weight (18.5Kg/m2 ≤ BMI < 25Kg/m2), overweight (25Kg/m2 ≤ BMI < 30Kg/m2) and obese (BMI ≥ 30Kg/m2 ).
5Normal waist-hip-ratio < 1.0 for men and <0.85 for women and elevated waist-hip-ratio >1.0 for men and >0.85 for women.
6Normal waist circumference < 94 cm for men and <80 cm for women, increased risk (94 cm > WC < 102 cm) for men and (80 cm > WC < 88 cm) for women and elevated ≥102 cm for men and ≥ 88 cm for women.